Matches in SemOpenAlex for { <https://semopenalex.org/work/W2802759092> ?p ?o ?g. }
- W2802759092 endingPage "95" @default.
- W2802759092 startingPage "88" @default.
- W2802759092 abstract "The NO/sGC/cGMP signaling cascade plays a pivotal role in regulation of cardiovascular, cardiopulmonary and cardiorenal diseases and impairment of this cascade results in severe pathologies. Therefore, pharmacological interventions, targeting this pathway are promising strategies for treating a variety of diseases. Nitrates, supplementing NO and, PDE5 inhibitors preventing cGMP degradation, are used for angina pectoris treatment and the treatment of pulmonary arterial hypertension (PAH), respectively. More recently, a new class of drugs which directly stimulate the sGC enzyme and trigger NO-independent cGMP production was introduced and termed sGC stimulators. In 2013, the first sGC stimulator, riociguat, was approved for the treatment of PAH and chronic thromboembolic pulmonary hypertension (CTEPH). Since cGMP targets multiple intracellular downstream targets, sGC stimulators have shown - beyond the well characterized vasodilatation – anti-fibrotic, anti-inflammatory and anti-proliferative effects. These additional modes of action might extend the therapeutic potential of this drug class substantially. This review summarizes the NO/sGC/cGMP signaling cascades, the discovery and the mode of action of sGC stimulators. Furthermore, the preclinical evidence and development of riociguat for the treatment of PAH and CTEPH is reviewed. Finally, a summary of the antifibrotic effects of sGC stimulators, especially the most recent finding for skin fibrosis are included which may indicate efficacy in fibrotic diseases like Systemic Sclerosis (SSc)." @default.
- W2802759092 created "2018-05-17" @default.
- W2802759092 creator A5021114284 @default.
- W2802759092 creator A5036087275 @default.
- W2802759092 creator A5079835977 @default.
- W2802759092 date "2018-07-01" @default.
- W2802759092 modified "2023-10-03" @default.
- W2802759092 title "Discovery and development of sGC stimulators for the treatment of pulmonary hypertension and rare diseases" @default.
- W2802759092 cites W1601887031 @default.
- W2802759092 cites W1788368306 @default.
- W2802759092 cites W180821421 @default.
- W2802759092 cites W1966310298 @default.
- W2802759092 cites W1978734517 @default.
- W2802759092 cites W1980023169 @default.
- W2802759092 cites W1990231940 @default.
- W2802759092 cites W1991993295 @default.
- W2802759092 cites W1998507098 @default.
- W2802759092 cites W2000386748 @default.
- W2802759092 cites W2003630942 @default.
- W2802759092 cites W2009257677 @default.
- W2802759092 cites W2013197944 @default.
- W2802759092 cites W2019941756 @default.
- W2802759092 cites W2033156522 @default.
- W2802759092 cites W2035837921 @default.
- W2802759092 cites W2037034743 @default.
- W2802759092 cites W2046150947 @default.
- W2802759092 cites W2049464390 @default.
- W2802759092 cites W2057720812 @default.
- W2802759092 cites W2058597109 @default.
- W2802759092 cites W2065528917 @default.
- W2802759092 cites W2085054033 @default.
- W2802759092 cites W2085361534 @default.
- W2802759092 cites W2087077223 @default.
- W2802759092 cites W2089172961 @default.
- W2802759092 cites W2090159456 @default.
- W2802759092 cites W2090700025 @default.
- W2802759092 cites W2097522152 @default.
- W2802759092 cites W2106524267 @default.
- W2802759092 cites W2107011819 @default.
- W2802759092 cites W2108559440 @default.
- W2802759092 cites W2108805152 @default.
- W2802759092 cites W2116338856 @default.
- W2802759092 cites W2118072086 @default.
- W2802759092 cites W2118073788 @default.
- W2802759092 cites W2120753380 @default.
- W2802759092 cites W2122386753 @default.
- W2802759092 cites W2123137799 @default.
- W2802759092 cites W2130500555 @default.
- W2802759092 cites W2132587013 @default.
- W2802759092 cites W2136030615 @default.
- W2802759092 cites W2138464262 @default.
- W2802759092 cites W2139954704 @default.
- W2802759092 cites W2142743112 @default.
- W2802759092 cites W2144845371 @default.
- W2802759092 cites W2148797779 @default.
- W2802759092 cites W2158262028 @default.
- W2802759092 cites W2158379683 @default.
- W2802759092 cites W2159495521 @default.
- W2802759092 cites W2160281474 @default.
- W2802759092 cites W2165473816 @default.
- W2802759092 cites W2167556957 @default.
- W2802759092 cites W2169220357 @default.
- W2802759092 cites W2171869994 @default.
- W2802759092 cites W2283092967 @default.
- W2802759092 cites W2313098007 @default.
- W2802759092 cites W2313158847 @default.
- W2802759092 cites W2331798828 @default.
- W2802759092 cites W2339042134 @default.
- W2802759092 cites W2467657054 @default.
- W2802759092 cites W2470147424 @default.
- W2802759092 cites W2512054829 @default.
- W2802759092 cites W2544208429 @default.
- W2802759092 cites W2548108365 @default.
- W2802759092 cites W2552293012 @default.
- W2802759092 cites W2590258025 @default.
- W2802759092 cites W2602635968 @default.
- W2802759092 cites W2614800967 @default.
- W2802759092 cites W2617300783 @default.
- W2802759092 cites W2776194376 @default.
- W2802759092 cites W2777236800 @default.
- W2802759092 cites W2782074409 @default.
- W2802759092 cites W2782796361 @default.
- W2802759092 cites W2789597224 @default.
- W2802759092 cites W2797298193 @default.
- W2802759092 cites W4230293260 @default.
- W2802759092 cites W4293430741 @default.
- W2802759092 doi "https://doi.org/10.1016/j.niox.2018.05.001" @default.
- W2802759092 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29738821" @default.
- W2802759092 hasPublicationYear "2018" @default.
- W2802759092 type Work @default.
- W2802759092 sameAs 2802759092 @default.
- W2802759092 citedByCount "25" @default.
- W2802759092 countsByYear W28027590922018 @default.
- W2802759092 countsByYear W28027590922019 @default.
- W2802759092 countsByYear W28027590922020 @default.
- W2802759092 countsByYear W28027590922021 @default.
- W2802759092 countsByYear W28027590922022 @default.
- W2802759092 crossrefType "journal-article" @default.